0001061983-13-000012.txt : 20130307 0001061983-13-000012.hdr.sgml : 20130307 20130307184506 ACCESSION NUMBER: 0001061983-13-000012 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130305 FILED AS OF DATE: 20130307 DATE AS OF CHANGE: 20130307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WOLFF ANDREW A CENTRAL INDEX KEY: 0001238406 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50633 FILM NUMBER: 13674857 MAIL ADDRESS: STREET 1: 280 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYTOKINETICS INC CENTRAL INDEX KEY: 0001061983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943291317 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 280 EAST GRAND AVENUE STREET 2: . CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 624-3000 MAIL ADDRESS: STREET 1: 280 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2013-03-05 0 0001061983 CYTOKINETICS INC CYTK 0001238406 WOLFF ANDREW A 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 0 1 0 0 SVP Clinical R&D, CMO Common Stock 67948 D Incentive Stock Option (right to buy) 1 2013-03-05 4 A 0 119103 0 A 2013-04-05 2023-03-05 Common Stock 119103 119103 D Non-Qualified Stock Option (right to buy) 1 2013-03-05 4 A 0 130897 0 A 2013-04-05 2023-03-05 Common Stock 130897 130897 D Incentive Stock Option (right to buy) 1.05 2012-04-05 2022-03-05 Common Stock 58665 58665 D Incentive Stock Option (right to buy) 1.57 2011-03-31 2021-02-28 Common Stock 58336 58336 D Incentive Stock Option (right to buy) 1.85 2009-03-26 2019-02-26 Common Stock 37917 37917 D Incentive Stock Option (right to buy) 3.08 2010-03-24 2020-02-24 Common Stock 42084 42084 D Incentive Stock Option (right to buy) 3.37 2008-03-29 2018-02-28 Common Stock 27935 27935 D Incentive Stock Option (right to buy) 6.59 2005-04-11 2015-04-11 Common Stock 781 781 D Incentive Stock Option (right to buy) 6.81 2007-04-01 2017-03-14 Common Stock 14185 14185 D Incentive Stock Option (right to buy) 7.15 2006-03-01 2016-03-01 Common Stock 17019 17019 D Incentive Stock Option (right to buy) 9.91 2005-09-20 2014-10-20 Common Stock 40360 40360 D Non-Qualified Stock Option (right to buy) 1.05 2012-04-05 2022-03-05 Common Stock 116335 116335 D Non-Qualified Stock Option (right to buy) 1.57 2011-03-31 2021-02-28 Common Stock 141664 141664 D Non-Qualified Stock Option (right to buy) 1.85 2009-03-26 2019-02-26 Common Stock 92083 92083 D Non-Qualified Stock Option (right to buy) 3.08 2010-03-24 2020-02-24 Common Stock 92916 92916 D Non-Qualified Stock Option (right to buy) 3.37 2008-03-29 2018-02-28 Common Stock 97065 97065 D Non-Qualified Stock Option (right to buy) 6.59 2005-04-11 2015-04-11 Common Stock 11719 11719 D Non-Qualified Stock Option (right to buy) 6.81 2007-04-01 2017-03-14 Common Stock 40815 40815 D Non-Qualified Stock Option (right to buy) 7.15 2006-03-01 2016-03-01 Common Stock 42981 42981 D Non-Qualified Stock Option (right to buy) 9.91 2005-09-20 2014-10-20 Common Stock 69640 69640 D Restricted Stock Units Common Stock 87500 87500 D When the ISO and NQ dated 03/05/2013 are combined for a total grant of 250,000 shares, the option shall vest and become exercisable as to 250,000 shares divided into equal monthly installments such that the option shall be 100% vested on 03/05/2017. When the ISO and NQ dated 03/05/2012 are combined for a total grant of 175,000 shares, the option shall vest and become exercisable as to 3,645 shares on 04/05/2012 and the balance of 171,355 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/05/2016. When the ISO and NQ dated 02/28/2011 are combined for a total grant of 200,000 shares, the option shall vest and become exercisable as to 4,166 shares on 03/31/2011 and the balance of 195,834 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/28/2015. When the ISO and NQ dated 02/26/2009 are combined for a total grant of 130,000 shares, the option shall vest and become exercisable as to 2,708 shares on 03/26/09 and the balance of 127,292 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/26/13. When the ISO and NQ dated 02/24/2010 are combined for a total grant of 135,000 shares, the option shall vest and become exercisable as to 2,812 shares on 03/24/2010 and the balance of 132,188 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/24/2014. When the ISO and NQ dated 02/29/2008 are combined for a total grant of 125,000 shares, the option shall vest and become exercisable as to 2,604 shares on 03/29/08 and the balance of 122,396 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/29/12. When the ISO and NQ dated 04/11/05 are combined for a total grant of 12,500 shares, the option shall vest and become exercisable as to 12,500 shares divided into equal monthly installments such that the option shall be 100% vested on 03/01/2009. When the ISO and NQ dated 03/14/2007 are combined for a total grant of 55,000 shares, the option shall vest and become exercisable as to 1,146 shares on 04/01/07 and the balance of 53,854 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/01/11. When the ISO and NQ dated 03/01/2006 are combined for a total grant of 60,000 shares, the option shall vest and become exercisable as to 60,000 shares divided into equal monthly installments such that the option shall be 100% vested on 03/01/2010. When the ISO and NQ dated 10/20/04 are combined for a total grant of 110,000 shares, the option shall vest and become exercisable as to 27,500 shares on 09/20/05 and the balance of 82,500 divided into equal monthly installments thereafter such that the option shall be 100% vested on 09/20/08. Each restricted stock unit represents a contingent right to receive one share of CYTK common stock at a purchase price of $0.001 per share which is the current par value of the common stock. The restricted stock units vest in two equal annual installments. Vested shares will be delivered to the reporting person on 9/4/2012 and 9/3/2013. Andrew A. Wolff, M.D. 2013-03-07